Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Mechanisms of Mindfulness Training and Stress Reduction

30 de janeiro de 2017 atualizado por: Carnegie Mellon University
This study is a three-arm randomized controlled trial of a mindfulness stress reduction intervention, with the aim of dismantling the experience-monitoring and nonjudgmental-acceptance elements of mindfulness programs to determine the active treatment component. In addition to enhancing understanding of mechanisms underlying the effects of mindfulness interventions, identifying the therapeutic constituent(s) could inform development of targeted interventions as well as provide strategies to optimize adherence.

Visão geral do estudo

Status

Concluído

Intervenção / Tratamento

Descrição detalhada

There is a growing body of randomized controlled trial (RCT) evidence indicating that mindfulness training interventions may reduce stress and improve stress-related disease outcomes. Yet little is known about the underlying active training mechanisms of mindfulness training. Although it is generally believed that mindfulness training interventions foster a capacity to monitor and accept present moment experience, debate currently focuses on whether it is the capacity to both monitor and non-judgmentally accept experience that drives the salutary effects observed in mindfulness training interventions. This project will test these putative active mechanisms by comparing two different types of mindfulness meditation training programs. N=135 stressed community adults will be recruited and randomized to either two different types of 8-week Mindfulness-Based Stress Reduction (MBSR) programs or a No Treatment Control (assessment only) comparison condition. Participants will complete 3 days of daily experience sampling (Ecological Momentary Assessment) immediately before and after the 8-week intervention period to measure attentional control and stress perceptions in daily life. In order to measure psychological and HPA-axis stress reactivity to a controlled stressor, participants will also complete a standardized acute stress challenge task (the Trier Social Stress Test, TSST) immediately following the 3-day post-intervention assessment period. This project provides the first dismantling study of mindfulness meditation training, it utilizes cutting-edge daily experience sampling of real life stress (using EMA) and stress biomarkers (salivary cortisol), and will provide important initial information for designing more effective (and efficient) mindfulness training interventions in at-risk stressed patient populations.

Tipo de estudo

Intervencional

Inscrição (Real)

137

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Pennsylvania
      • Pittsburgh, Pennsylvania, Estados Unidos, 15213
        • Carnegie Mellon University
      • Pittsburgh, Pennsylvania, Estados Unidos, 15232
        • University of Pittsburgh Medical Center- Center for Integrative Medicine
      • University Park, Pennsylvania, Estados Unidos, 16802
        • Pennsylvania State University

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 70 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • English speaking
  • Moderate- to high-stress
  • Owns an internet-enabled smart phone

Exclusion Criteria:

  • Diagnosis of chronic mental (e.g. recurrent depression, schizophrenia, personality disorder) or physical disease (e.g. cancer, HIV, diabetes)
  • Hospitalization in past 3 months
  • Medication use that interferes with cortisol activity (e.g. corticosteroids)
  • Current oral contraceptive use
  • Pregnancy
  • Current antibiotic, antiviral, or antimicrobial treatment
  • Travel outside the country within the past 6 months to any country on the Center for Disease Control travel alert list
  • Recreational drug use, excessive alcohol or tobacco use
  • Significant experience with or daily practice of mindfulness meditation or related mind-body practice

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Dobro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Comparador Ativo: Mindfulness Training
Mindfulness training intervention consisting of eight weekly 2.5 hour group sessions, a day-long retreat in the sixth week, and daily home mindfulness meditation
Mindfulness training practices aim to foster attention and acceptance toward one's present moment experience. Mindfulness consists of two components-- (1) deploying attention to monitor one's moment-to-moment experience, and (2) fostering an attitude of acceptance toward one's moment-to-moment experience
Comparador Ativo: Mindful Attention Only Training
Mindful attention only training intervention consisting of eight weekly 2.5 hour group sessions, a day-long retreat in the sixth week, and daily home mindfulness meditation
Mindfulness training practices aim to foster attention and acceptance toward one's present moment experience. Mindfulness consists of two components-- (1) deploying attention to monitor one's moment-to-moment experience, and (2) fostering an attitude of acceptance toward one's moment-to-moment experience
Sem intervenção: No Treatment Control Condition
No treatment participants will be informed that their participation is important and that they are requested to not seek out similar treatments during this waiting period.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Prazo
Daily life stress assessed via Ecological Momentary Assessment
Prazo: change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks
change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks

Medidas de resultados secundários

Medida de resultado
Prazo
Daily life state attention and acceptance assessed via Ecological Momentary Assessment
Prazo: change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks
change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks
Subjective stress in response to social evaluative threat
Prazo: assessed at post-intervention, which is an average of 14 weeks
assessed at post-intervention, which is an average of 14 weeks
Salivary Cortisol in response to social evaluative threat
Prazo: assessed at post-intervention, which is an average of 14, at time 0, and 25, 35, and 60 minutes post-stress challenge
assessed at post-intervention, which is an average of 14, at time 0, and 25, 35, and 60 minutes post-stress challenge
Blood Pressure reactivity to social evaluative threat (systolic and diastolic blood pressure)
Prazo: assessed at post-intervention, which is an average of 14 weeks, at 2-minute intervals during session
assessed at post-intervention, which is an average of 14 weeks, at 2-minute intervals during session
Sustained attention measured by the Dichotic Listening Task
Prazo: change from baseline to post-intervention, which is an average of 14 weeks
change from baseline to post-intervention, which is an average of 14 weeks
Sustained inattentional blindness measured by the Inattentional Blindness Task
Prazo: post-intervention only
post-intervention only

Outras medidas de resultado

Medida de resultado
Prazo
Daily life affect assessed via Ecological Momentary Assessment
Prazo: change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks
change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks
Daily life social interactions assessed via Ecological Momentary Assessment
Prazo: change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks
change from baseline 3-day period to post-intervention 3-day period, which is an average of 12 weeks
Perceived stress using the Perceived Stress Scale
Prazo: change from baseline to post-intervention, which is an average of 14 weeks
change from baseline to post-intervention, which is an average of 14 weeks
Attentional control using the Attentional Control Scale
Prazo: change from baseline to post-intervention, which is an average of 14 weeks
change from baseline to post-intervention, which is an average of 14 weeks
Treatment expectancies
Prazo: post-intervention an average of 14 weeks after the baseline
post-intervention an average of 14 weeks after the baseline
Subjective responses to the training program intervention
Prazo: composite of ratings made after each intervention lesson, an average of 10 weeks following baseline
composite of ratings made after each intervention lesson, an average of 10 weeks following baseline
Mindfulness using the Mindful Attention Awareness Scale
Prazo: change from baseline to post-intervention, which is an average of 14 weeks
change from baseline to post-intervention, which is an average of 14 weeks

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Cadeira de estudo: Wendy Weber, Ph.D., National Center for Complementary and Integrative Health, National Institutes of Health

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de julho de 2015

Conclusão Primária (Real)

1 de janeiro de 2017

Conclusão do estudo (Real)

1 de janeiro de 2017

Datas de inscrição no estudo

Enviado pela primeira vez

7 de julho de 2015

Enviado pela primeira vez que atendeu aos critérios de CQ

16 de julho de 2015

Primeira postagem (Estimativa)

20 de julho de 2015

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

1 de fevereiro de 2017

Última atualização enviada que atendeu aos critérios de controle de qualidade

30 de janeiro de 2017

Última verificação

1 de janeiro de 2017

Mais Informações

Termos relacionados a este estudo

Termos MeSH relevantes adicionais

Outros números de identificação do estudo

  • 1R21AT008493-01A1 (Concessão/Contrato do NIH dos EUA)

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever